A new analysis of more than 28,000 adverse event reports submitted to the U.S. Food and Drug Administration over eight years has found that caffeinated energy drinks and stimulant supplements were linked to serious cardiovascular events far more often than other products. The preliminary research, to be presented at the American Heart Association’s Scientific Sessions 2026, highlights a potential safety concern for a product category that has more than doubled in sales over the past decade, reaching over $20 billion in 2024.
Researchers analyzed 28,345 reports made to an FDA safety database between 2017 and 2025. Of those, 854 mentioned caffeine- or stimulant-containing energy drinks or dietary supplements, and these were compared with 27,491 reports about products without such ingredients. The findings showed that cardiac arrest was reported about 11 times more often in connection with caffeine- and stimulant-containing products. Reports involving these products were also about 4.5 times more likely to include heart attacks and four times more likely to include ventricular arrhythmias or heart palpitations.
Other cardiovascular conditions followed similar patterns: elevated heart rate was reported nearly three times more often, chest pain 2.71 times more often, and fainting about twice as often. Notably, about 45% of the reports linking these products to cardiovascular events involved adults ages 18 to 34—a group not typically considered at high risk for cardiovascular events.
“These products are marketed as everyday pick-me-ups and sold next to soda and bottled water, so most people assume they carry no real risk,” said study author Sai Samayamanthula, a fourth-year medical student at the University of Virginia School of Medicine. “For many healthy people, if these products are consumed occasionally, the risk is probably small. However, individuals who consume energy drinks or other stimulant-containing supplements regularly can quickly exceed the recommended daily limit for caffeine, so it’s important for people to know that there may be a risk of cardiovascular harm with these products.”
According to a 2026 American Heart Association Scientific Statement on caffeine and cardiovascular disease, consuming up to 400 mg of caffeine per day is generally safe for most adults. However, some energy drinks contain as much as three times more caffeine per fluid ounce than brewed coffee, and some pre-workout supplements contain more than 12 times as much. Since the FDA regulates these products as foods or dietary supplements rather than medications, they do not undergo the same premarket safety testing required for drugs.
Gregory M. Marcus, M.D., chair of the 2026 American Heart Association scientific statement on caffeine and cardiovascular disease, cautioned that the study does not prove causation. “Although there are biological reasons why that connection could be possible, the study does not prove that caffeine products cause these events, because other factors may have influenced the results found in this analysis,” said Marcus, who was not involved in the study. He added that more research is needed to understand whether these stimulant products are truly responsible for the reported heart-related events.
The researchers emphasized that the analysis only identified associations based on voluntary reports to the FDA and cannot establish direct cause and effect. They also noted that the findings point to types of products rather than any single brand. The implications are significant: with energy drink consumption rising, especially among young adults, the study authors call for more systematic safety monitoring of caffeine- and stimulant-containing products and urge healthcare professionals to ask younger patients about their consumption of these products when they present with palpitations, chest pain, or fainting. As Samayamanthula noted, the findings support the case for greater vigilance. The abstract is available in the American Heart Association’s Online Program Planner, and additional resources, including expert commentary, can be found via the release link.


